Clinical Trial Update: Metformin/Rosuvastatin Combination Therapy With in Patients With Type 2 Diabetes and Dyslipidemia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating a metformin and rosuvastatin combination in patients with type 2 diabetes mellitus and dyslipidemia has completed. Spon…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Type 2 Diabetes Mellitus

Drugs mentioned

• Rosuvastatin (rosuvastatin)
• metformin (metformin)

Snippet

Sponsor: Jeil Pharmaceutical Co., Ltd. | Conditions: Type 2 Diabetes, Dyslipidemia | Phase 3 | Status: COMPLETED